Heart ultrasound to see how the Impella pump affects both heart chambers
Uses heart ultrasound to study Impella 5.5 in adults with end-stage heart failure.
Key facts
- Who runs it
- University of Rochester
- Where
- Rochester, United StatesSee the site
- Trial code
- Registry title
- Echocardiographic Assessment of the Effect of Impella on Biventricular Function
- Status
- Recruiting
- People taking part
- 24 people, planned
- Started
- 11 Jul 2026
- Expected to end
- 1 Jul 2027
- Type of study
- Observational
- Treatments tested
- Echocardiographic Assessment
- Record updated
- 9 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with end-stage heart failure who need an Impella 5.5 heart pump. Heart scans will track how the pump affects both sides of the heart.
- Age
- Over 18 years old
- Sex
- All sexes can join
- Disease stage
- End-stage heart failure that needs temporary mechanical circulatory support
Main reasons for not taking part
- Cannot give consent for themselves, including not understanding the research
- Higher-than-normal risk of problems from the heart ultrasound through the throat, such as swallowing problems (dysphagia) or esophagus disease
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Adult patients over 18 years old
- Require Impella 5.5 implantation
Who cannot take part
- Patients' inability to provide consent for themselves (including that patients' lack of understanding the research)
- Any patients who are deemed at higher-than-normal risk for complications secondary to echocardiography, such as dysphagia or esophageal pathology
Where in United States
- University of Rochester Medical CenterRochester, United StatesContact: YOSHIHISA MORITATaking people
About the trial
What the trial wants to find out
The objective of this prospective observational study is to evaluate the effects of Impella 5.5 on biventricular function in adult patients with end-stage heart failure requiring temporary mechanical circulatory support. The study will assess changes in left and right ventricular global longitudinal strain and myocardial work, as well as additional echocardiographic and hemodynamic parameters. Measurements will be obtained at baseline prior to Impella implantation, immediately after device initiation, and during postoperative follow-up up to Day 14. This study involves collection of echocardiographic imaging and clinical data, including additional imaging performed for research purposes.
The group in the trial
- End-stage heart failure patients receiving Impella 5.5
Adult patients with end-stage heart failure requiring Impella 5.5 for temporary mechanical circulatory support.
Treatment: Echocardiographic Assessment
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Echocardiographic Assessment of the Effect of Impella on Biventricular Function
- Plain-language title
- Heart ultrasound to see how the Impella pump affects both heart chambersGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 9 September 2026